Oncternal Therapeutics In... (ONCT)
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 9:00 PM
Oncternal Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Cash & Equivalents | 6.7M | 37.14M | 90.77M | 116.74M | 20.05M | 28.26M | 15.82M | 8.91M | 14.06M | 17.88M | 14.53M | 48.04M | 63.74M | 58.18M | 40.22M | 95.51M | 100.18M | 119.55M | 74.01M | 64.53M | 14.77M | 8.93M | 8.83M | 2.67M | 1.54M |
| Short-Term Investments | 27.56M | 26.58M | n/a | n/a | n/a | 200K | 28.08M | 12.96M | 15.2M | 31.41M | 200K | 8.04M | 10.7M | 450K | 8.82M | 2.16M | 9.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 412K | 1.27M | 657K | 766K | 767K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 728K | 1.39M | 83K | 450K | 1.47M | n/a | n/a | n/a | n/a |
| Receivables | 632K | 178K | 944K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9K | 981K | 683K | 595K | 1.26M | 40.84M | 61K | 153K | n/a | -255K | n/a | n/a | n/a | n/a |
| Inventory | n/a | 103K | -944K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 161K | 171K | 116K | 92K | 78K | 207K | 135K | 448K | 194K | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.17M | 3.39M | 1.5M | 2.53M | 1.47M | 2.75M | 2.79M | 4.86M | 5.27M | 1.71M | 884K | 1.44M | 1.27M | 1.75M | 920K | 1M | 1.36M | 3.76M | 1.7M | 1.18M | 316K | 41K | n/a | n/a | n/a |
| Total Current Assets | 36.06M | 67.29M | 92.85M | 118M | 20.79M | 31.21M | 46.08M | 24.3M | 31.89M | 50.15M | 15.17M | 56.81M | 76.85M | 60.36M | 50.67M | 100.02M | 152.26M | 121.7M | 76M | 66.15M | 15.02M | 8.97M | 8.83M | 2.67M | 1.54M |
| Property-Plant & Equipment | 258K | 87K | 75K | 40K | 190K | 19K | 51K | 81K | 5K | 29K | 112K | 507K | 1.1M | 2.04M | 3.29M | 3.99M | 2.31M | 1.45M | 1.75M | 1.54M | 815K | 1.06M | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | 94K | 108K | 123K | 137K | 471K | 322K | 452K | 240K | 1.85M | 3.75M | 4.09M | 4.43M | 4.71M | 4.98M | 4.94M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 670K | 1.36M | 732K | 806K | 957K | 113K | 159K | 204K | 142K | 500K | 434K | 959K | 1.34M | 3.89M | 7.05M | 8.09M | 7.47M | 7.55M | 6.81M | 6.93M | 2.29M | 1.06M | n/a | n/a | n/a |
| Total Assets | 36.73M | 68.65M | 93.58M | 118.81M | 21.74M | 31.32M | 46.24M | 24.5M | 32.03M | 50.65M | 15.61M | 57.77M | 78.18M | 64.25M | 57.72M | 108.11M | 159.73M | 129.25M | 82.81M | 73.08M | 17.31M | 10.03M | 10.12M | 3.2M | 1.68M |
| Account Payables | 1.15M | 2.92M | 1.96M | 1.14M | 871K | 3.28M | 2.6M | 1.22M | 382K | 512K | 808K | 1.71M | 1.22M | 848K | 1.27M | 2.82M | 1.61M | 1.34M | 1.41M | 900K | 461K | 601K | n/a | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | 1.63M | 3.64M | n/a | -200K | n/a | n/a | n/a | n/a | -7K | 1.34M | 1.34M | 9.95M | 11.49M | 10.93M | 5.85M | 1.34M | 1.34M | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 173K | 87K | 75K | 40K | 198K | n/a | n/a | n/a | n/a | n/a | n/a | 7K | 82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 3.88M | 4.68M | 3.43M | 3.04M | 2.63M | 1.93M | 5.37M | 3.39M | 29.79M | 32.28M | 3.76M | 7.78M | 4.78M | 3.11M | 4.73M | 6.67M | 6.78M | 3.15M | 3.23M | 2.62M | 1.79M | 711K | n/a | n/a | n/a |
| Total Current Liabilities | 5.2M | 7.68M | 5.46M | 5.86M | 7.34M | 5.21M | 7.97M | 4.61M | 30.17M | 32.79M | 4.57M | 9.49M | 6.08M | 5.3M | 15.95M | 20.98M | 19.33M | 10.34M | 5.97M | 4.85M | 2.25M | 1.31M | n/a | n/a | n/a |
| Long-Term Debt | 145K | n/a | n/a | n/a | 91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10K | 15K | 20K | 24K | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 354K | 578K | 234K | 497K | 621K | 382K | 226K | 300K | 280K | n/a | 165.29M | 64.03M | n/a | n/a | n/a |
| Total Long-Term Liabilities | 1.48M | 3M | n/a | n/a | 91K | 47.26M | n/a | n/a | n/a | 30K | 354K | 578K | 234K | 7.22M | 50.52M | 55.11M | 61.48M | 21.87M | 3.26M | 4.32M | 165.29M | 64.03M | n/a | n/a | n/a |
| Total Liabilities | 6.68M | 7.68M | 5.46M | 5.86M | 7.43M | 5.21M | 7.97M | 4.61M | 30.17M | 32.82M | 4.92M | 10.07M | 6.31M | 12.52M | 66.47M | 76.09M | 80.81M | 32.21M | 9.23M | 9.17M | 167.54M | 65.34M | 44.19M | 28.37M | 1.66M |
| Total Debt | 318K | 87K | 75K | 40K | 190K | 46.59M | 200K | n/a | n/a | n/a | n/a | 7K | n/a | n/a | n/a | n/a | 10K | 15K | 20K | 24K | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 3K | 57K | 49K | 49K | 15K | 24K | 22K | 16K | 141K | 140K | 63K | 63K | 63K | 52K | 36K | 36K | 36K | 35K | 31K | 25K | 8K | 8K | n/a | n/a | n/a |
| Retained Earnings | -197.78M | -158.3M | -114.13M | -82.8M | -65.57M | -600.05M | -561.64M | -531.2M | -513.47M | -494.77M | -455.36M | -413.25M | -386.17M | -352.88M | -368.17M | -321.92M | -270.14M | -229.78M | -194.27M | -157.43M | -151.75M | -56.28M | -35.05M | -26.14M | -949K |
| Comprehensive Income | 3K | 9K | n/a | -0.00 | n/a | -2.63M | -2.67M | -2.64M | -2.85M | -3.75M | -3.67M | -8.76M | -8.11M | -7.14M | -6.49M | -5.07M | -3.84M | -2.68M | -1.73M | -2.7M | -3.5M | n/a | n/a | n/a | n/a |
| Shareholders Equity | 30.05M | -158.3M | -114.13M | -82.8M | 14.31M | 26.11M | 38.26M | 19.89M | 1.86M | 17.83M | 10.68M | 47.7M | 71.87M | 51.73M | -8.75M | 32.02M | 78.92M | 97.05M | 73.58M | 63.91M | -150.23M | -55.31M | -34.08M | -25.16M | 21K |
| Total Investments | 27.56M | 26.58M | n/a | n/a | n/a | 200K | 28.08M | 12.96M | 15.2M | 31.41M | 200K | 8.04M | 10.7M | 450K | 8.82M | 2.16M | 9.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |